DERM
Journey Medical Corp
NASDAQ: DERM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.15
+3.00% today
Updated 2026-04-30
Market cap
$171.27M
P/E ratio
—
P/S ratio
2.77x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$4 – $10
Volume
0.2M
Journey Medical Corp (DERM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-31.40M | $-48.44M | $-74.11M | $-103.96M | $-213.10M | $9.02M | $5.13M | $-2.18M | $-13.53M | $5.24M | $-9.13M | $-12.44M |
| Capital expenditures | $156000.00 | $202000.00 | $753000.00 | $278000.00 | $616000.00 | $2.40M | $1.20M | $10.00M | $20.00M | $5.00M | $15.00M | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.64M | $5.13M | $11.00M | $20.70M | $29.84M | $240000.00 | $153000.00 | $2.47M | $4.42M | $2.61M | $6.10M | $6.29M |
| Free cash flow | $-31.56M | $-48.64M | $-74.86M | $-104.24M | $-213.71M | $6.62M | $3.93M | $-12.18M | $-33.53M | $240000.00 | $-24.13M | $-12.44M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | $1.55M | $371000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — |